Fig. 2From: The consequences of implementing non-invasive prenatal testing with cell-free foetal DNA for the detection of Down syndrome in the Spanish National Health Service: a cost-effectiveness analysisDiagram representing the first- and second-trimester screening (current screening)Back to article page